{{Rsnum
|rsid=9909601
|Gene=E2F3P1
|Chromosome=17
|position=35490403
|Orientation=plus
|GMAF=0.2713
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 14.2 | 35.4 | 50.4
| HCB | 10.9 | 45.3 | 43.8
| JPT | 7.1 | 30.1 | 62.8
| YRI | 0.7 | 15.8 | 83.6
| ASW | 3.5 | 26.3 | 70.2
| CHB | 10.9 | 45.3 | 43.8
| CHD | 10.1 | 42.2 | 47.7
| GIH | 5.0 | 33.7 | 61.4
| LWK | 0.0 | 15.6 | 84.4
| MEX | 8.6 | 34.5 | 56.9
| MKK | 0.0 | 14.7 | 85.3
| TSI | 7.8 | 43.1 | 49.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23720677
|Title=Genetic variants in pseudogene E2F3P1 confer risk for HBV-related hepatocellular carcinoma in a Chinese population
|OA=1
}}

{{PMID Auto
|PMID=25013402
|Title=A genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinoma
}}
{{on chip | Affy GenomeWide 6}}